{
  "resourceType" : "ValueSet",
  "id" : "ATCTargetCLL",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet ATCTargetCLL</b></p><a name=\"ATCTargetCLL\"> </a><a name=\"hcATCTargetCLL\"> </a><a name=\"ATCTargetCLL-en-US\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"CodeSystem-GenericValues.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-none\">none</a></td><td>Ingen</td><td>None - used to choose none of the available values</td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-other\">other</a></td><td>Anden pathway inhibitor</td><td>Other - used to choose unspecific value not in a valueset</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-ATC.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01EL01\">L01EL01</a></td><td>Ibrutinib</td><td>L01EL01 - ibrutinib</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01EM01\">L01EM01</a></td><td>Idelalisib</td><td>L01EM01 - idelalisib</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01XX52\">L01XX52</a></td><td>Venetoclax</td><td>L01XX52 - venetoclax</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01EL02\">L01EL02</a></td><td>Acalabrutinib</td><td>L01EL02 - acalabrutinib</td></tr></table></li></ul></div>"
  },
  "url" : "https://kip.rkkp.dk/fhir/ValueSet/ATCTargetCLL",
  "version" : "2.11.2",
  "name" : "ATCTargetCLL",
  "title" : "ATC_CLL_target",
  "status" : "active",
  "experimental" : true,
  "date" : "2022-07-13T00:00:00+02:00",
  "publisher" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
  "contact" : [{
    "name" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
    "telecom" : [{
      "system" : "url",
      "value" : "https://trifork.com"
    },
    {
      "system" : "email",
      "value" : "rbk@trifork.com"
    }]
  }],
  "description" : "ATC koder targeteret behandling - [CLL]",
  "compose" : {
    "include" : [{
      "system" : "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues",
      "concept" : [{
        "code" : "none",
        "display" : "Ingen"
      },
      {
        "code" : "other",
        "display" : "Anden pathway inhibitor"
      }]
    },
    {
      "system" : "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
      "concept" : [{
        "code" : "L01EL01",
        "display" : "Ibrutinib"
      },
      {
        "code" : "L01EM01",
        "display" : "Idelalisib"
      },
      {
        "code" : "L01XX52",
        "display" : "Venetoclax"
      },
      {
        "code" : "L01EL02",
        "display" : "Acalabrutinib"
      }]
    }]
  }
}